How to Read a Clinical Trial About Ayurvedic Herbs

What this article covers

By the end of this guide you will be able to:

Read a study abstract and identify the trial design, sample size, duration, and primary outcome. Recognise common methodological weaknesses that should reduce your confidence in a finding. Distinguish between in-vitro, animal, and human evidence. Understand what "p < 0.05" actually means and what it doesn't. Find a study yourself on PubMed and check it against marketing claims. Know the difference between "statistically significant" and "clinically meaningful."

This is the foundation that makes the rest of HerbVerdict's evidence framework usable.

The hierarchy of evidence — why some studies count more than others

Not all studies are equal. The clinical-research community has spent decades developing a hierarchy that ranks evidence types by how much weight they should carry in decisions.

The pyramid is the single most important concept in this article. When a brand cites "studies show," your first question should be: what level of the pyramid is the study? An in-vitro finding (bottom) is interesting biology but not clinical proof. A meta-analysis of multiple RCTs (top) is the strongest evidence we typically have outside of regulatory drug-approval data.

Most "studies show" marketing claims for Ayurvedic supplements rely on in-vitro or animal evidence. Reading the actual cited paper usually reveals this gap.

What is a clinical trial?

A clinical trial is a structured experiment that tests a specific intervention (a herb, drug, treatment, or procedure) in human participants under controlled conditions, with predefined outcomes measured before and after the intervention.

Clinical trials are typically described in phases. Phase 1 establishes safety and dosing in small healthy volunteer groups (typically 20-80 people). Phase 2 evaluates efficacy and side effects in patients with the target condition (100-300 people). Phase 3 confirms efficacy and monitors adverse reactions in larger populations (1,000-3,000 people). Phase 4 covers post-marketing surveillance after a treatment is approved.

For Ayurvedic herbs, most clinical research lives in Phase 1 or Phase 2 territory. Few Ayurvedic herbs have completed Phase 3 trials, and even fewer have Phase 4 data. This is one of the reasons HerbVerdict's verdicts are calibrated more cautiously than pharmaceutical drug evidence — the trial base is generally smaller and earlier-stage.

RCT explained — the gold standard

A Randomised Controlled Trial (RCT) is the methodologically strongest design for testing whether an intervention causes an outcome. Three features make it the gold standard.

A well-designed RCT can answer the question "does this intervention cause this outcome?" with reasonable confidence. A poorly-designed RCT — small sample, short duration, no real control, multiple ad-hoc outcome changes — answers nothing useful even if it gets published.

Placebo and blinding

This is the section that confuses readers most because the concepts are subtle.

For Ayurvedic herb trials, blinding is sometimes difficult — many herbs have distinctive smells, tastes, or appearances that make them hard to disguise. The Ashwagandha studies we cite often note this limitation: participants may have correctly guessed their group assignment from the herb's earthy smell.

Sample size — why n matters

The "n" in a study (e.g., n=60) is the number of participants. Sample size matters because small studies produce noisy results that may or may not replicate.

A 30-person trial showing a 20% improvement could be a real effect or random variation. A 300-person trial showing the same 20% improvement is much more likely to reflect a real effect. Statisticians have formal tools (statistical power calculations) to estimate the sample size needed to detect a given effect with a given confidence.

For Ayurvedic herb research, sample sizes vary widely: - Small trials (n < 30): Common in older Ayurvedic literature. Findings should be treated as preliminary. - Medium trials (n = 30-100): The most common range for modern Ayurvedic RCTs. Findings are interpretable but warrant replication. - Large trials (n > 100): Less common for Ayurvedic herbs. Findings carry more weight. - Multi-centre trials with n > 200: The strongest evidence type. Rare for Ayurvedic single-herb research.

When a brand cites "research shows" with an n=15 trial, that's preliminary evidence at best. When the cited evidence is a meta-analysis pooling multiple RCTs to n=400+, that's much stronger ground.

P-values — what they mean and don't mean

This is the section where most public-health communication fails. Let me explain it clearly.

A p-value is a probability calculated by statistical tests, expressing how likely it is that you would observe the difference your trial found if there were actually no real difference between the groups.

When a paper reports "p < 0.05," it means: if there were truly no effect, the probability of seeing this result by chance alone is less than 5%. The convention is to call results "statistically significant" if p < 0.05.

What p < 0.05 does NOT mean: - It does not mean "the herb works." It means "the result is unlikely to be pure chance." - It does not mean "5% probability of being wrong." That's a common misinterpretation. - It does not measure the size of the effect — only its statistical reliability. - It does not mean "clinically meaningful." A tiny statistically significant effect may be clinically irrelevant.

A more useful question than "is p < 0.05?" is "what is the effect size?" — i.e., how big is the actual change, and is it big enough to matter to a patient?

Effect size — what changes by how much

Effect size measures the magnitude of an intervention's effect on the outcome, separate from statistical significance.

Common effect size measures include: - Mean difference: The raw change (e.g., LDL cholesterol reduced by 15 mg/dL) - Standardised mean difference (SMD): A normalised measure used in meta-analyses - Relative risk reduction: Useful for binary outcomes (e.g., 30% fewer infections)

A statistically significant result with tiny effect size may be clinically uninteresting. A barely-not-significant result with large effect size may still warrant follow-up research. Both questions matter.

When reading a trial summary, look for both: "is the result statistically significant?" AND "is the effect size big enough to matter?"

Limitations to watch for

This is the checklist I run through for every Ayurvedic herb trial I evaluate.

A trial can be high-quality on most of these dimensions and weak on one or two. Perfect trials are rare. The skill is weighing the limitations against the strength of the finding.

How to find and check a study yourself

This is the practical skill that makes all of the above usable.

This is more work than most consumers will do for any individual product. But for a herb you're considering taking long-term, this 20-minute exercise is a defensible time investment.

How HerbVerdict's verdict system maps to all this

We use three verdict tiers across our scorecards:

The framework forces us to be specific about what evidence supports each verdict, rather than relying on general impressions.

What "clinically proven" usually means on a label (and what it should mean)

When you see "clinically proven" on an Ayurvedic supplement, here is the spectrum of what it could actually mean:

The actual specific product has been tested in a published RCT (rare). The herb in general has been tested in some RCTs (common). An ingredient in the product has been tested in some preclinical studies (very common). Someone wrote a marketing brochure saying it works (most common).

The first interpretation is the only one that justifies "clinically proven" as a claim. The other three should not be marketed that way, but often are. A more sophisticated consumer asks: "what specific product was tested in what specific trial?" If a brand can answer with citations, the claim is defensible. If not, treat it as marketing.

Common Ayurveda research red flags — a checklist for marketing claims

This is where the framework actually becomes useful for everyday consumer decisions.

When you see "clinically proven" or "research shows" on an Ayurvedic supplement, run through this checklist:

A reader who runs this checklist on every supplement marketing claim will quickly find that most claims fail multiple items. That's not a paranoia exercise — it's just calibrated consumer literacy.

What "evidence-based supplementation" actually looks like

The phrase "evidence-based" gets used loosely in consumer wellness marketing. Here is what it actually means in practice.

Evidence-based supplementation means: choosing supplements where the specific intervention you are taking matches what was tested in published clinical trials at meaningful sample size, with replicated findings, in populations similar to yours, for outcomes relevant to your goals.

This is a narrow standard. Most consumer supplement use does not meet it. That's not necessarily a problem — many people take supplements for traditional, cultural, or general wellness reasons that don't require clinical-trial-level evidence justification.

But "evidence-based" should mean something specific. When a brand uses the phrase, they should be able to point to specific clinical trial evidence that matches their specific product. Most can't. A more honest version of supplement marketing would distinguish between "this herb has a research base" and "this specific product has trial-level evidence" — they are different claims.

Frequently asked questions

Related reads on HerbVerdict